DexCom (DXCM) faces GLP-1 disruption as it targets non-insulin Type 2 CGM growth. Read here for a detailed invesment analysis ...
AI may help smartwatches make glucose data more useful through better predictions, pattern detection, and personalized health ...
Following expanded FDA approval for pediatric patients, the over-the-counter Stelo continuous glucose monitor is adding AI ...
A new initiative integrated personal continuous glucose monitor reports into routine primary care visits for diabetes.
Smartwatches may transform blood sugar tracking, but today’s advances depend on CGMs, AI, and regulated health tech ...
Parents of young children with elevated blood sugar now have a new option that does not require a doctor’s prescription. The ...